beta

AMPE

Ampio Pharmaceuticals, Inc.

Ampe

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.

Market Cap: 62.3 Million

Primary Exchange: NYSE American

Website: http://www.ampiopharma.com

Shares Outstanding: 159 Million

Float: 147 Million

Dividend: (%)

Beta: 0.775284051365059

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Animal testing

Longest drawdown: 1550 trading days

From: 2013-10-24 To: 2019-12-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud